Diagnostic Kiosk To Offer 65 Tests Free Of Cost At Manewada UPHC
The kiosk was inaugurated on Thursday by South Nagpur MLA Mohan Mate.
The kiosk, equipped with a 12-lead ECG, digital stethoscope, dermascope, otoscope, ANC camera, and webcam, is designed to conduct over 65 tests. It also supports teleconsultation and live videoconferencing. The tests which the kiosk could conduct include HBC, diabetes, thyroid, HIV, urine, kidney, uric acid, Covid, hepatitis, pregnancy and many others.
The kiosk will provide significant convenience to underprivileged patients visiting the health centre. Mate said this initiative will be a significant step in healthcare services, as expensive diagnostic tests will now be available free of cost and within minutes.
Medical health officer Dr Deepak Selokar, Manewada centre's medical officer Dr Meenal Patle, former corporator Mangala Khekre, Abhishek Maykar from Maykar Innovation Pvt Ltd, responsible for operating the kiosk, and Pooja Gupta, were present.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around
Blinkist: Warren Buffett's Reading List
Undo
Many poor patients visit the UPHC for treatment. To enhance the facilities, Mate had discussed the provision of the diagnostic healthcare kiosk with NMC commissioner and administrator Dr Abhijeet Chaudhary. The commissioner, along with additional commissioner Vasumana Pant took special interest in the matter and conducted periodic inspections of the machine. The kiosk was approved only after verifying the accuracy of its test reports against those of private pathology labs.
Dr Deepak Selokar said the kiosk will also facilitate testing for high-risk patients.
In addition to the Manewada UPHC, diagnostic healthcare kiosks will also be installed at Dighori, Nandanvan, Bidipeth, Somwari Quarter UPHCs, and Indira Gandhi Hospital. Trained staff has been arranged to operate these kiosks at each centre.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
He's not a traffic cop, yet this 72-year-old from Delhi has been managing traffic for past 32 years without pay. Who is Gangaram?
Some individuals dedicate their entire existence to noble causes, driven not by recognition or rewards, but by the deep desire to bring positive change to the world around them. Their contentment lies in knowing their efforts might prevent pain for others. In a bustling corner of Delhi, one such man quietly carries out his mission. Seventy-two-year-old Gangaram has been regulating traffic at the chaotic Seelampur junction for over three decades, all without expecting a salary. He isn't part of the traffic police, nor has he been officially appointed by any authority. Yet, every single day, clad in a uniform and wielding a baton, he spends over 10 hours managing the flow of vehicles with utmost dedication. His decision to take on this role was born from personal tragedy. Years ago, Gangaram's son was killed in a road mishap at the same Seelampur signal where he now works. The two used to run a modest TV and electronics repair shop in the neighborhood. After losing his only child and, shortly thereafter, his wife—who couldn't bear the emotional weight of the loss—Gangaram found himself utterly alone. Grief-stricken but resolute, he turned his sorrow into a mission: to prevent such accidents from claiming more lives. Explore courses from Top Institutes in Please select course: Select a Course Category Healthcare Operations Management Product Management healthcare Degree Artificial Intelligence Finance Digital Marketing Management Design Thinking Data Science Others Leadership Technology Cybersecurity CXO Public Policy PGDM MCA others MBA Data Analytics Data Science Project Management Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details Even during the peak of the COVID-19 pandemic, when elderly citizens were urged to remain indoors for their safety, Gangaram never stayed home. His unwavering commitment to managing traffic continued, despite the risks. Rain, heat, or lockdown—nothing could deter him. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo Recently, his story caught the internet's attention when the widely followed platform Instant Bollywood shared his journey. The post quickly went viral, garnering over 16,000 likes and heartfelt reactions. Social media users flooded the comment section with admiration, calling for national recognition of his service and praising his courage and sense of responsibility. Gangaram remains a poignant reminder of how one man's grief can be transformed into a lifelong mission to protect others—an everyday hero guarding Delhi's roads, asking for nothing in return.
Time of India
2 hours ago
- Time of India
So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!
For many living with type 2 diabetes, managing blood sugar is a daily reality. Often, medications come as a lifeline, and among them, sulfonylureas like glipizide are popular choices, especially in the US. They've been around for decades, are affordable, and have shown effective results in keeping glucose in check. But now, a new study has cast a shadow over this commonly used medicine. Researchers have discovered a possible link between glipizide and increased heart-related risks. Here's what the study found, what it truly means, and why this matters to families where diabetes is part of everyday conversations. Glipizide: Familiar, trusted, But now under scrutiny Glipizide belongs to a group of drugs called sulfonylureas. For decades, these medications have been trusted for lowering blood sugar in people with type 2 diabetes, often when metformin alone isn't enough. What made glipizide popular was its affordability and long-standing availability. But popularity doesn't always mean perfection. The latest study signals a possible red flag. Involving nearly 48,000 individuals, this research found that those taking glipizide had a higher risk of heart attacks, strokes, heart failure hospitalisations, and even cardiovascular-related deaths than those taking a newer class of drugs called DPP-4 inhibitors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo The numbers that raised eyebrows The research compared glipizide with other sulfonylureas like glimepiride and glyburide, along with DPP-4 inhibitors. Here's what stood out: Over a 5-year period, the risk of major heart events was 9.1% in those taking glipizide, while for those on DPP-4 inhibitors, it was 8.1%. The risk ratio for glipizide users was 1.13, indicating a 13% higher risk of cardiovascular events compared to DPP-4 inhibitor users. The risk was also slightly higher with glimepiride (8.6%) and glyburide (8.4%), but not statistically significant. What makes this important is that most participants were on their second diabetes medication after metformin, a common scenario in diabetes care. And they weren't at extremely high cardiac risk to begin with, just moderate, everyday individuals managing a chronic condition. Not just about the numbers, but about what they mean It's easy to be alarmed by statistics. But what do these numbers truly tell us? Firstly, the study doesn't claim that glipizide causes heart problems directly. What it suggests is a possible association, a pattern that raises concerns, especially in people already facing moderate cardiovascular risk. The heart, after all, is already under pressure in type 2 diabetes. When a drug meant to help with sugar control potentially adds to that risk, even slightly, it becomes a serious discussion for healthcare providers. Why affordability might come at a cost Sulfonylureas like glipizide are often the go-to option in low- and middle-income settings because they're inexpensive. DPP-4 inhibitors, on the other hand, are costlier but have a more favourable cardiovascular safety profile. This raises a deeper, more sensitive question: should treatment decisions depend on cost or safety? The answer isn't straightforward. But studies like this push for better informed decisions, where doctors weigh more than just sugar levels, they also look at heart health, overall risk, and long-term quality of life. What this means for families dealing with diabetes This isn't about pushing panic buttons. Glipizide is still an approved and effective drug. But the study offers important insights for personalised diabetes management. It's a reminder that medications work differently for different people, and what works well for one might not be ideal for another, especially when silent risks like cardiovascular strain are involved. It's also a cue to revisit older medications with a fresh lens, especially when newer, safer options are available. The story here isn't about fear, but about awareness and agency. (Inputs from agencies)
News18
2 hours ago
- News18
MBBS Without NEET? Study Medicine In These 5 Countries
1/8 For many Indian students aspiring to become doctors, cracking the NEET exam can be a daunting hurdle. However, several countries offer quality MBBS education without requiring NEET scores and at a fraction of the cost compared to private medical colleges in India. (Image: Canva) Russia: Russia is one of the most popular destinations for Indian medical aspirants. Many of its government universities are recognised by international medical bodies. The low tuition fees, subsidised accommodation, and strong Indo-Russian ties make it a favourable choice. Top universities include Bashkir State Medical University and Kazan Federal University. (Image: Canva) Kyrgyzstan: Kyrgyzstan has emerged as a top low-cost destination for Indian students due to its simplified admission process, low cost of living, and presence of NMC-approved universities. Hostel facilities and Indian food are also commonly available, making it a student-friendly choice. (Image: Canva) Kazakhstan: Kazakhstan is also known for its affordable education and good infrastructure. Medical universities here offer high-quality education and sufficient clinical exposure. Many Indian students choose this country due to its relatively easy visa process and cultural familiarity. (Image: Canva) bChinese medical universities attract thousands of Indian students every year. While NEET is not always required for admission, it is needed to return and practice in India. The curriculum, infrastructure, and exposure to advanced medical technology are some of the highlights. (Image: Canva) Philippines: The Philippines offers an American-style medical curriculum and is a preferred destination due to its cultural similarity, tropical climate, and affordable education. Students also benefit from strong English proficiency across the country, easing communication in hospitals and classrooms. (Image: Canva) While these countries may not require NEET for admission, Indian students must qualify NEET if they wish to appear for the FMGE (Foreign Medical Graduate Examination) in India and practice as a doctor. It is also important to verify whether the medical university is recognised by the National Medical Commission (NMC) before applying. (Image: Canva)
